Рет қаралды 16,431
On Aug 19, 2022 Axsome Therapeutics announced the FDA Approval of Auvelity, as the first and Only Oral NMDA Receptor Antagonist for the treatment of Major Depressive Disorder in adults.
(CORRECTION: In the mechanism section, it is SIGMA RECEPTOR AGONISM & NOT ANTAGONISM)
We have summarized this FDA-approved medication in the following
Psychiatry Education Forum Academy Updates:
Read Details: psychiatryeducationforum.com/...